Giulia Ceglie 1,2*, Giulia Nocentini3*, Francesca De Gennaro 3,
Vitangelo Clemente 3, Margherita Di Mauro3, Giuseppe Palumbo 1,3
1 Department of Pediatric Hematology and Oncology,
Cell and Gene Therapy, IRCCS Bambino Gesù Children’s Hospital, Rome,
Italy
2 PhD Program in Immunology, Molecular Medicine and
Applied Biotechnology, University of Rome Tor Vergata, 00133 Rome, Italy
3 University Department of Pediatrics, Bambino Gesù
Children’s Hospital, University of Rome Tor Vergata, Rome, Italy
*These authors contributed equally.
Correspondence : Giulia Ceglie, M.D., Department of Pediatric
Hematology and Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù
Children’s Hospital, Piazza Sant’Onofrio 4, 00165, Rome, Italy